Analyst Recommendations

Citigroup analyst issues BUY recommendation for PDD on January 20, 2026 11:00AM ET. The previous analyst recommendation was Buy.PDD was trading at $106.703 at issue of the analyst...

January 20, 2026   PDD 1.17%

Wells Fargo analyst issues OVERWEIGHT recommendation for ARGX on January 20, 2026 11:11AM ET. The previous analyst recommendation was Overweight.ARGX was trading at $800.01 at issue of the...

January 20, 2026   ARGX -0.91%

Jefferies analyst issues BUY recommendation for HLN on January 20, 2026 11:43AM ET. The previous analyst recommendation was Buy.HLN was trading at $9.83 at issue of the analyst...

January 20, 2026   HLN -0.10%

Citigroup analyst issues BUY recommendation for AU on January 20, 2026 11:43AM ET. The previous analyst recommendation was Buy.AU was trading at $99.03 at issue of the analyst...

January 20, 2026   AU 9.99%

Goldman Sachs analyst issues NEUTRAL recommendation for FMS on January 20, 2026 09:24AM ET. FMS was trading at $21.95 at issue of the analyst recommendation.The overall analyst consensus...

January 20, 2026   FMS 0.64%

Morgan Stanley analyst issues UNDERWEIGHT recommendation for WIT on January 19, 2026 04:29PM ET. WIT was trading at $2.75 at issue of the analyst recommendation.The overall analyst consensus...

January 19, 2026   WIT 0.75%

RBC Capital analyst issues OUTPERFORM recommendation for AU on January 19, 2026 05:21AM ET. The previous analyst recommendation was Sector Perform.AU was trading at $99.03 at issue of...

January 19, 2026   AU 9.99%

UBS analyst issues SECTOR PERFORM recommendation for AU on January 19, 2026 05:16AM ET. The previous analyst recommendation was Buy.AU was trading at $99.03 at issue of the...

January 19, 2026   AU 9.99%

Deutsche Bank analyst issues SELL recommendation for AZN on January 16, 2026 07:10PM ET. The previous analyst recommendation was Sell.AZN was trading at $94.27 at issue of the...

January 16, 2026   AZN 0.06%

Deutsche Bank analyst issues HOLD recommendation for GSK on January 16, 2026 07:11PM ET. The previous analyst recommendation was Hold.GSK was trading at $48.34 at issue of the...

January 16, 2026   GSK 1.59%